ArticleScientific reports2026
Sex-related differences in cardiovascular inflammation and metabolomics in a humanized transgenic mouse model of celiac disease.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Celiac disease (CeD) is an immune-mediated disorder driven by dietary gluten, characterized by intestinal, such as diarrhoea and malabsorption, and many extraintestinal manifestations. Epidemiological studies have linked untreated CeD to an elevated risk of cardiovascular complications. In this study, CeD induced in humanized transgenic male NOD.DQ8 mice resulted in vascular dysfunction, cardiovascular oxidative stress, and systemic as well as vascular inflammation. In contrast, female NOD-DQ8 mice developed comparable CeD-specific small intestinal pathology upon gluten exposure but were protected from vascular dysfunction and cardiovascular inflammation. Compared with females, male CeD mice displayed pronounced dysregulation of cholesterol metabolism, activation of the kynurenine pathway, and mast cell activation in perivascular tissues. Pharmacological reduction of estrogen with the aromatase inhibitor letrozole partly impaired vascular dilatation in female CeD mice. These findings underscore the importance of considering sex-specific manifestations of CeD with its associated systemic inflammation in preclinical and clinical research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.